Visit-to-visit HbA1c variability, dementia, and hippocampal atrophy among adults without diabetes

Chenxi Li1, Junyan Guo1, Yining Zhao1

  • 1School of Public Health, The Second Affiliated Hospital, The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China.

PubMed

Insights

High hemoglobin A1c (HbA1c) variability in adults without diabetes is linked to increased dementia risk and reduced hippocampal volume. Monitoring HbA1c fluctuations is important for brain health in this population.

Area of Science:

  • Neurology
  • Endocrinology
  • Gerontology

Background:

  • Hemoglobin A1c (HbA1c) management is critical for diabetes patients.
  • The health implications of HbA1c variability in non-diabetic adults are not well understood.
  • Adults without diabetes may have underlying health issues impacting cognitive function.

Purpose of the Study:

  • To investigate the association between visit-to-visit HbA1c variability and incident dementia in non-diabetic adults.
  • To examine the relationship between HbA1c variability and hippocampal volume in this population.
  • To provide insights into managing HbA1c fluctuations for cognitive health in apparently healthy individuals.

Main Methods:

  • Prospective analysis of 10,792 UK Biobank participants without diabetes.
  • HbA1c variability calculated as ([latter - former]/mean) over two sequential visits.
  • Dementia incidence identified via hospital records; hippocampal volume measured using MRI.

Main Results:

  • Over 8.4 years, 90 participants developed dementia.
  • High HbA1c variability (above 0.08) correlated with increased dementia risk (HR 1.88).
  • Increased HbA1c variability was also associated with lower hippocampal volume (coefficient -96.84 mm³).

Conclusions:

  • Visit-to-visit HbA1c variability is linked to higher dementia risk in non-diabetic adults.
  • Increased HbA1c fluctuation is associated with reduced hippocampal volume.
  • Monitoring and controlling HbA1c variability may be crucial for maintaining brain health in adults without diabetes.
Abstract

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
539
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
606
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
144